Associations of tonsillar hypertrophy and snoring with history of wheezing in childhood

Pediatric Pulmonology

Volumn 45, Issue 3, 2010, Pages 275-280

  Kaditis, Athanasios G ^a   Kalampouka, Efthimia ^a   Hatzinikolaou, Souzana ^a   Lianou, Loukia ^a   Papaefthimiou, Maria ^a   Gartagani Panagiotopoulou, Polytimi ^a   Zintzaras, Elias ^b   Chrousos, George ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Asthma; Obstructive sleep apnea; Snoring; Wheezing

Indexed keywords

ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SNORING; TONSIL DISEASE; TONSILLAR HYPERTROPHY; WHEEZING;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTROPHY; MALE; ODDS RATIO; PALATINE TONSIL; PHYSICAL EXAMINATION; RESPIRATORY SOUNDS; SLEEP APNEA SYNDROMES; SNORING;

EID: 77449098388     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21174     Document Type: Article

References (39)

1. Arens R, Marcus CL. Pathophysiology of upper airway obstruction: A developmental perspective. Sleep 2004;27: 997-1019.
2. National Heart Lung,Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report. Bethesda, MD: Guidelines for the Diagnosis and Management of Asthma; 2007.
3. Julien JY, Martin JG, Ernst P, Olivenstein R, Hamid Q, Lemiere C, Pepe C, Naor N, Olha A, Kimoff RJ. Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol 2009;124:371-376.
4. Larsson LG, Lindberg A, Franklin KA, Lundback B. Symptoms related to obstructive sleep apnoea are common in subjects with asthma, chronic bronchitis and rhinitis in a general population. Respir Med 2001;95:423-429.
5. Fitzpatrick MF, Martin K, Fossey E, Shapiro CM, Elton RA, Douglas NJ. Snoring asthma and sleep disturbance in Britain: A community-based survey. Eur Respir J 1993;6:531-535.
6. Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G. Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 1999;159:1527-1532.
7. Corbo GM, Fuciarelli F, Foresi A, De Benedetto F. Snoring in children: Association with respiratory symptoms and passive smoking. BMJ 1989;299:1491-1494.
8. Teculescu DB, Caillier I, Perrin P, Rebstock E, Rauch A. Snoring in French preschool children. Pediatr Pulmonol 1992;13: 239-244.
9. Ersu R, Arman AR, Save D, Karadag B, Karakoc F, Berkem M, Dagli E. Prevalence of snoring and symptoms of sleep-disordered breathing in primary school children in Istanbul. Chest 2004;126:19-24.
10. Lu LR, Peat JK, Sullivan CE. Snoring in preschool children: Prevalence and association with nocturnal cough and asthma. Chest 2003;124:587-593.
11. Kaditis AG, Alexopoulos E, Chaidas K, Ntamagka G, Karathanasi A, Tsilioni I, Kiropoulos TS, Zintzaras E, Gourgoulianis K. Urine concentrations of cysteinyl leukotrienes in children with obstructive sleep-disordered breathing. Chest 2009;135:1496-1501.
12. Wilson AM, O'Byrne PM, Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: A systematic review and meta-analysis. Am J Med 2004;116:338-344.
13. Goldbart AD, Krishna J, Li RC, Serpero LD, Gozal D. Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 2006;130:143-148.
14. Jame AJ, Lackie PM, Cazaly AM, Sayers I, Penrose JF, Holgate ST, Sampson AP. Human bronchial epithelial cells express an active and inducible biosynthetic pathway for leukotrienes B4 and C4. Clin Exp Allergy 2007;37:880-892.
15. Zhu J, Qiu YS, Figueroa DJ, Bandi V, Galczenski H, Hamada K, Guntupalli KK, Evans JF, Jeffery PK. Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa. Am J Respir Cell Mol Biol 2005;33:531-540.
16. Kalra M, Lemasters G, Bernstein D,Wilson K, Levin L, Cohen A, Amin R. Atopy as a risk factor for habitual snoring at age 1 year. Chest 2006;129:942-946.
17. Dayyat E, Serpero LD, Kheirandish-Gozal L, Goldman JL, Snow A, Bhattacharjee R, Gozal D. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest 2009;135:1142-1149.
18. Goldbart AD, Mager E, Veling MC, Goldman JL, Kheirandish-Gozal L, Serpero LD, Piedimonte G, Gozal D. Neurotrophins and tonsillar hypertrophy in children with obstructive sleep apnea. Pediatr Res 2007;62:489-494.
19. Kaditis AG, Ioannou MG, Chaidas K, Alexopoulos EI, Apostolidou M, Apostolidis T, Koukoulis G, Gourgoulianis K. Cysteinyl leukotriene receptors are expressed by tonsillar T cells of children with obstructive sleep apnea. Chest 2008;134:324-331.
20. Snow A, Dayyat E, Montgomery-Downs HE, Kheirandish-Gozal L, Gozal D. Pediatric obstructive sleep apnea: A potential late consequence of respiratory syncytial virus bronchiolitis. Sleep 2008;31:A75.
21. Kaditis AG, Lianou L, Hatzinikolaou S, Kalampouka E, Gartagani- Panayiotopoulou P, Zintzaras E, Chrousos G. Tonsillar size in 2- to 14-year old children with and without snoring. Pediatr Pulmonol 2009;44:1216-1222.
22. Kaditis AG, Finder J, Alexopoulos EI, Starantzis K, Tanou K, Gampeta S, Agorogiannis E, Christodoulou S, Pantazidou A, Gourgoulianis K, Molyvdas PA. Sleep-disordered breathing in 3,680 Greek children. Pediatr Pulmonol 2004;37:499-509.
23. Kaditis AG, Alexopoulos EI, Kostadima E, Kaditis DG, Pastaka C, Zintzaras E, Gourgoulianis K. Comparison of blood pressure measurements in children with and without habitual snoring. Pediatr Pulmonol 2005;39:408-414.
24. Alexopoulos EI, Kostadima E, Pagonari I, Zintzaras E, Gourgoulianis K, Kaditis AG. Association between primary nocturnal enuresis and habitual snoring in children. Urology 2006;68: 406-409.
25. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL. Centers for disease control and prevention 2000 growth charts for the united states: Improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-60.
26. Brodsky L. Modern assessment of tonsils and adenoids. Pediatr Clin North Am 1989;36:1551-1569.
27. Kaditis AG, Alexopoulos EI, Hatzi F, Karadonta I, Chaidas K, Gourgoulianis K, Zintzaras E, Syrogiannopoulos GA. Adiposity in relation to age as predictor of severity of sleep apnea in children with snoring. Sleep Breath 2008;12:25-31.
28. Gozal D, Capdevila OS, Kheirandish-Gozal L. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med 2008;177:1142-1149.
29. Kaditis AG, Alexopoulos EI, Kalampouka E, Kostadima E, Angelopoulos N, Germenis A, Zintzaras E, Gourgoulianis K. Morning levels of fibrinogen in children with sleep-disordered breathing. Eur Respir J 2004;24:790-797.
30. Li AM, Hung E, Tsang T, Yin J, So HK,Wong E, Fok TF, Ng PC. Induced sputum inflammatory measures correlate with disease severity in children with obstructive sleep apnoea. Thorax 2007;62:75-79.
31. Lin CC, Lin CY. Obstructive sleep apnea syndrome and bronchial hyperreactivity. Lung 1995;173:117-126.
32. McColley SA, Carroll JL, Curtis S, Loughlin GM, Sampson HA. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 1997;111:170-173.
33. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-545.
34. Winther B, Gwaltney JM, Jr., Mygind N, Turner RB, Hendley JO. Sites of rhinovirus recovery after point inoculation of the upper airway. Jama 1986;256:1763-1767.
35. Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, Johnston SL. Frequency severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: A longitudinal cohort study. Lancet 2002;359:831-834.
36. Gern JE, Vrtis R, Grindle KA, Swenson C, Busse WW. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000;162:2226-2231.
37. Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL. A defective type 1 response to rhinovirus in atopic asthma. Thorax 2002;57:328-332.
38. Javadyan A, Papadopoulos NG, Kafetzis DA. Rhinovirus infections and adenoidal hypertrophy: Do they interact with atopy in children? Expert Rev Anti Infect Ther 2003;1:223-229.
39. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 2005;172:364-370.